With the latest fusion technologies in mind, Aurora proudly presents its product portfolio. Guided by the philosophy of minimally invasive surgeries, our products are designed to match the patient’s anatomy; from our ISP devices to Interbody cages, Biologics, and our Surgical Tools, Aurora is dedicated to bringing you products that will help the patient and improve their quality of life.
Aurora Spine Corporation (TSXV:ASG) announced today(1/5/2016) that more than 1,000 ZIP® MIS Interspinous Fusion Devices have now been implanted in patients around the world undergoing spinal fixation procedures.
Aurora Spine Corporation (TSXV:ASG) announced today(04/28/2015) the first surgical implantations of the company's ZIP 51™ Minimally Invasive Interspinous Implant in the United States and Germany.
Aurora Spine Corporation (TSXV:ASG) announced today(04/15/2015) that it will be will be presenting at the 15th Annual ISSAS Conference in San Diego, CA April 15-17, 2015 at Booth 411.
Aurora Spine Corporation (TSX VENTURE:ASG) announced today(02/09/2015) the first surgical implant of the company's ZIP ULTRA™ minimally invasive interspinous device in Switzerland. This surgery is part of Aurora Spine's continuing efforts to expand the use of our ZIP MIS Fusion System in Europe. The surgery was performed at the Clinique Générale-Beaulieu in Geneva by Prof. Aymen Ramadan.
Aurora Spine Corporation (TSX-V:ASG) announced today(12/10/2014) that it will be participating at the 2014 DWG (Deutscher Wirbelsäulenkongress) Trade Show Conference from Thursday, December 11th to Saturday, December 13th in the "Congress Center Leipzig", Leipzig, Germany.
Aurora Spine Corporation (TSXV:ASG) announced today(12/09/2014) that it has received the Health Canada Medical Device License for its ZIP™ Interspinous Fusion System. Aurora Spine's ZIP MIS Interspinous fixation implant for spinal fusion, consists of a ONE-STEP™ locking mechanism, articulating spikes and various sizes to accommodate variations in patient anatomy which eliminates the use of a set screw.
Aurora Spine Corporation (TSX VENTURE:ASG) announced today(11/22/2014) that it will be presenting at the Brean Capital Life Sciences Summit Conference in New York, NY on November 24, 2014. Brean Capital's Corporate Access product offering includes a number of industry-specific and regional "best idea" investment conferences to facilitate the interaction of company management and institutional investors throughout the year.
Aurora Spine Corporation (TSX VENTURE:ASG) announced today(11/18/2014) that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ZIP 51™, Aurora Spine's slimmest minimally invasive interspinous fixation implant for spinal fusion.
Aurora Spine Corporation (TSX VENTURE:ASG) announced today(10/31/2014) the first surgical implant of the company's ZIP ULTRA™ Minimally Invasive interspinous device in Israel. Multiple surgeries have now been performed at the Herzliya Medical Center by Prof. Reuven Gepstein.
Aurora Spine Corporation (TSX VENTURE:ASG) announced it has entered into a national contract with MedAssets. MedAssets is one of the nation's largest third-party providers of supply chain management and outsourced procurement capabilities. MedAssets manages, on behalf of its clients, more than $50 billion in supply expense per year through the MedAssets National Procurement Center.